CopyMark Law Group
4.9
Drawing for GORTEC

USPTO serial 79433752

GORTEC

Reviewed by CopyMark Law Group

Reg. 8200465Status 700Registered
Filing date
Status date
Registration date
Apr 7, 2026
Examiner
MILMOE, MAUREEN H
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with GORTEC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Goods and services

ClassDescriptionStatusFirst use
041Training in the field of oncology; Training in the field of clinical studies and clinical trials; Written text editing, other than publicity texts, for clinical studies and trials; Publishing of journals, scientific papers, books and handbooks in the field of clinical studies and clinical trials; Online publication of electronic magazines in the field of oncology; Publication and editing of printed matter in the field of oncology; Organizing and conducting colloquiums, conferences and congresses in the field of oncology; Organizing and conducting colloquiums, conferences and congresses in the field of clinical studies and clinical trialsACTIVE—
042Medical and scientific research, namely, conducting clinical studies and clinical trials for others; Medical and scientific research, namely, conducting clinical studies and clinical trials for others in the field of oncology; Providing information on clinical studies and clinical trials via an interactive website; Providing information on clinical studies and clinical trials in the field of oncology via an interactive website; Providing a website featuring educational information in the field of clinical research; Scientific research in the nature of conducting clinical trials for others; Scientific research in the nature of conducting clinical studies for others; Providing medical and scientific research information in the field of pharmaceuticals; Providing medical and scientific research information in the fields of clinical studies and clinical trials; Scientific and technological services, namely, computerized analysis of technical data in the field of clinical trials and clinical studiesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 7, 2026FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Apr 7, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Apr 7, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 26, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Feb 17, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 17, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 11, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 5, 2026RFNTREFUSAL PROCESSED BY IB—
Jan 23, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 22, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 22, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 22, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 16, 2026RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jan 16, 2026RFRRREFUSAL PROCESSED BY MPU—
Dec 10, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 9, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 8, 2025DOCKASSIGNED TO EXAMINER—
Oct 3, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 3, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 2, 2025REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance